HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Matsuzawa Selected Research

OSU8 1

10/2000Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Matsuzawa Research Topics

Disease

16Atherosclerosis
09/2003 - 04/2000
15Obesity
11/2002 - 01/2000
14Insulin Resistance
08/2005 - 02/2000
11Type 2 Diabetes Mellitus (MODY)
03/2015 - 01/2000
7Neoplasms (Cancer)
11/2001 - 03/2000
7Coronary Artery Disease (Coronary Atherosclerosis)
09/2001 - 06/2000
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2007 - 02/2000
6Body Weight (Weight, Body)
09/2003 - 12/2000
5Diabetes Mellitus
10/2011 - 01/2001
5Type 1 Maturity-Onset Diabetes of the Young
04/2003 - 01/2000
5Mason-Type Diabetes
04/2003 - 01/2000
5Cholesteryl Ester Transfer Protein Deficiency
11/2001 - 10/2000
4Glucose Intolerance
03/2015 - 12/2000
4Hypertension (High Blood Pressure)
10/2011 - 01/2000
4Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2011 - 09/2001
4Vascular Diseases (Vascular Disease)
12/2008 - 01/2001
4Hepatocellular Carcinoma (Hepatoma)
05/2003 - 07/2000
4Colorectal Neoplasms (Colorectal Cancer)
05/2001 - 07/2000
3Type 3 Maturity-Onset Diabetes of the Young
08/2002 - 09/2000
2Dyslipidemias (Dyslipidemia)
10/2011 - 03/2001
2Inflammation (Inflammations)
12/2008 - 06/2005
2Hypoadiponectinemia
12/2008 - 05/2001
2Necrosis
06/2003 - 03/2001
2Leukemia
06/2003 - 06/2000
2Hyperlipidemias (Hyperlipidemia)
10/2001 - 08/2000
2Melanoma (Melanoma, Malignant)
10/2001 - 01/2001
2Tangier Disease
09/2001 - 11/2000
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2001 - 01/2001
2Weight Loss (Weight Reduction)
08/2001 - 06/2000
2Platelet Glycoprotein IV Deficiency
06/2001 - 07/2000
2Neoplasm Metastasis (Metastasis)
05/2001 - 01/2001
2Atherosclerotic Plaque (Atheroma)
04/2001 - 05/2000
1Erythema Multiforme
08/2010
1Crohn Disease (Crohn's Disease)
06/2005
1Fistula
06/2005
1Anorexia Nervosa
09/2003
1Weight Gain
09/2003
1Chronic Kidney Failure (Chronic Renal Failure)
09/2003
1Malnutrition (Nutritional Deficiencies)
09/2003
1Myocardial Infarction
06/2003

Drug/Important Bio-Agent (IBA)

22AdiponectinIBA
10/2011 - 02/2000
18Proteins (Proteins, Gene)FDA Link
06/2005 - 02/2000
11Glucose (Dextrose)FDA LinkGeneric
03/2015 - 01/2000
9Insulin (Novolin)FDA Link
07/2013 - 01/2000
9CholesterolIBA
11/2002 - 08/2000
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2007 - 02/2000
7Lipoproteins (Lipoprotein)IBA
05/2003 - 10/2000
7Hepatocyte Nuclear FactorsIBA
04/2003 - 01/2000
5Transcription Factors (Transcription Factor)IBA
10/2001 - 01/2000
4AdipokinesIBA
12/2008 - 02/2000
4AutoantibodiesIBA
09/2001 - 02/2000
4Scavenger Receptors (Scavenger Receptor)IBA
06/2001 - 04/2000
3AntibodiesIBA
08/2005 - 02/2000
3Triglycerides (Triacylglycerol)IBA
03/2003 - 08/2000
3Blood Proteins (Serum Proteins)IBA
11/2002 - 09/2000
3Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA
08/2002 - 09/2000
3ApolipoproteinsIBA
10/2001 - 03/2001
3Cholesterol Ester Transfer ProteinsIBA
06/2001 - 10/2000
3Apolipoproteins B (ApoB)IBA
06/2001 - 03/2001
3CytokinesIBA
05/2001 - 02/2000
3HDL CholesterolIBA
03/2001 - 10/2000
3EnzymesIBA
11/2000 - 01/2000
2Phosphates (Orthophosphate)IBA
08/2010 - 03/2000
2Plasminogen Activator Inhibitor 1IBA
12/2008 - 01/2001
2Dexamethasone (Maxidex)FDA LinkGeneric
05/2003 - 08/2000
2PPAR gammaIBA
11/2001 - 04/2000
2HDL LipoproteinsIBA
09/2001 - 03/2001
2LigandsIBA
09/2001 - 10/2000
2Amino AcidsFDA Link
09/2001 - 08/2000
2Biological ProductsIBA
08/2001 - 06/2001
2Codon (Codons)IBA
06/2001 - 05/2000
2Cholesterol Esters (Cholesteryl Esters)IBA
06/2001 - 03/2001
2BetacellulinIBA
04/2001 - 12/2000
2Epidermal Growth Factor (EGF)IBA
04/2001 - 05/2000
2Plasminogen Activators (Plasminogen Activator)IBA
03/2001 - 01/2001
2LipidsIBA
03/2001 - 02/2001
2Nonesterified Fatty Acids (NEFA)IBA
03/2001 - 02/2000
2Immunoglobulin G (IgG)IBA
01/2001 - 08/2000
2Complementary DNA (cDNA)IBA
11/2000 - 01/2000
2AntigensIBA
11/2000 - 03/2000
2Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
10/2000 - 05/2000
2Messenger RNA (mRNA)IBA
09/2000 - 07/2000
2InterferonsIBA
07/2000 - 06/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2000 - 03/2000
1dihydrocodeineFDA LinkGeneric
08/2010
1Fas Ligand Protein (Fas Ligand)IBA
08/2005
1CreatinineIBA
09/2003
1NF-kappa B (NF-kB)IBA
06/2003
1Cholecystokinin B ReceptorIBA
06/2003
1Protein Kinase CIBA
06/2003
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
06/2003
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
06/2003
1GastrinsIBA
06/2003
1Phosphotransferases (Kinase)IBA
06/2003

Therapy/Procedure

2Bone Marrow Transplantation (Transplantation, Bone Marrow)
06/2003 - 08/2000
1Kidney Transplantation
09/2003
1Patient Discharge
09/2003
1Renal Dialysis (Hemodialysis)
09/2003
1Cell Transplantation
06/2003
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2003